ANTICORPOS HUMANOS QUE SE LIGAM A IL-12 HUMANA E MÉTODOS PARA PRODUÇÃO
Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12 ) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MICHAEL PASKIND AMY VENTURINI SARAH LEILA DU FOU ANGELA WIDOM JOCHEN G. SALFELD BORIS LABKOVSKY SARA CARMEN SUBHASHIS BANERJEE GEERTRUIDA M. VELDMAN JOHN GAWAIN ELVIN THOR LAS HOLTET STEPHEN SMITH DANIEL EDWARD TRACEY MICHAEL WHITE NICHOLAS W. WARNE ELAINE J. DERBYSHIRE ZEHRA KAYMAKCALAN ALEXANDER ROBERT DUNCAN STUART FRIEDRICH MICHAEL ROGUSKA PAUL SAKORAFAS ANGELA MYLES |
| description | Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12 ) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0721125A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0721125A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0721125A23</originalsourceid><addsrcrecordid>eNrjZPB09AvxdPYPCvAPVvAI9XX0A9KBoa4Kwa4KPp7ujr4KjgqePrqGRhBJRwVXBd_DnSH-LkBlAY5BjgoBQf4uoYfbDzf78zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeKegAE8DcyNDQyNTRyNjohQBACTLL3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICORPOS HUMANOS QUE SE LIGAM A IL-12 HUMANA E MÉTODOS PARA PRODUÇÃO</title><source>esp@cenet</source><creator>MICHAEL PASKIND ; AMY VENTURINI ; SARAH LEILA DU FOU ; ANGELA WIDOM ; JOCHEN G. SALFELD ; BORIS LABKOVSKY ; SARA CARMEN ; SUBHASHIS BANERJEE ; GEERTRUIDA M. VELDMAN ; JOHN GAWAIN ELVIN ; THOR LAS HOLTET ; STEPHEN SMITH ; DANIEL EDWARD TRACEY ; MICHAEL WHITE ; NICHOLAS W. WARNE ; ELAINE J. DERBYSHIRE ; ZEHRA KAYMAKCALAN ; ALEXANDER ROBERT DUNCAN ; STUART FRIEDRICH ; MICHAEL ROGUSKA ; PAUL SAKORAFAS ; ANGELA MYLES</creator><creatorcontrib>MICHAEL PASKIND ; AMY VENTURINI ; SARAH LEILA DU FOU ; ANGELA WIDOM ; JOCHEN G. SALFELD ; BORIS LABKOVSKY ; SARA CARMEN ; SUBHASHIS BANERJEE ; GEERTRUIDA M. VELDMAN ; JOHN GAWAIN ELVIN ; THOR LAS HOLTET ; STEPHEN SMITH ; DANIEL EDWARD TRACEY ; MICHAEL WHITE ; NICHOLAS W. WARNE ; ELAINE J. DERBYSHIRE ; ZEHRA KAYMAKCALAN ; ALEXANDER ROBERT DUNCAN ; STUART FRIEDRICH ; MICHAEL ROGUSKA ; PAUL SAKORAFAS ; ANGELA MYLES</creatorcontrib><description>Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12 ) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.</description><language>por</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140311&DB=EPODOC&CC=BR&NR=PI0721125A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140311&DB=EPODOC&CC=BR&NR=PI0721125A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MICHAEL PASKIND</creatorcontrib><creatorcontrib>AMY VENTURINI</creatorcontrib><creatorcontrib>SARAH LEILA DU FOU</creatorcontrib><creatorcontrib>ANGELA WIDOM</creatorcontrib><creatorcontrib>JOCHEN G. SALFELD</creatorcontrib><creatorcontrib>BORIS LABKOVSKY</creatorcontrib><creatorcontrib>SARA CARMEN</creatorcontrib><creatorcontrib>SUBHASHIS BANERJEE</creatorcontrib><creatorcontrib>GEERTRUIDA M. VELDMAN</creatorcontrib><creatorcontrib>JOHN GAWAIN ELVIN</creatorcontrib><creatorcontrib>THOR LAS HOLTET</creatorcontrib><creatorcontrib>STEPHEN SMITH</creatorcontrib><creatorcontrib>DANIEL EDWARD TRACEY</creatorcontrib><creatorcontrib>MICHAEL WHITE</creatorcontrib><creatorcontrib>NICHOLAS W. WARNE</creatorcontrib><creatorcontrib>ELAINE J. DERBYSHIRE</creatorcontrib><creatorcontrib>ZEHRA KAYMAKCALAN</creatorcontrib><creatorcontrib>ALEXANDER ROBERT DUNCAN</creatorcontrib><creatorcontrib>STUART FRIEDRICH</creatorcontrib><creatorcontrib>MICHAEL ROGUSKA</creatorcontrib><creatorcontrib>PAUL SAKORAFAS</creatorcontrib><creatorcontrib>ANGELA MYLES</creatorcontrib><title>ANTICORPOS HUMANOS QUE SE LIGAM A IL-12 HUMANA E MÉTODOS PARA PRODUÇÃO</title><description>Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12 ) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPB09AvxdPYPCvAPVvAI9XX0A9KBoa4Kwa4KPp7ujr4KjgqePrqGRhBJRwVXBd_DnSH-LkBlAY5BjgoBQf4uoYfbDzf78zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeKegAE8DcyNDQyNTRyNjohQBACTLL3A</recordid><startdate>20140311</startdate><enddate>20140311</enddate><creator>MICHAEL PASKIND</creator><creator>AMY VENTURINI</creator><creator>SARAH LEILA DU FOU</creator><creator>ANGELA WIDOM</creator><creator>JOCHEN G. SALFELD</creator><creator>BORIS LABKOVSKY</creator><creator>SARA CARMEN</creator><creator>SUBHASHIS BANERJEE</creator><creator>GEERTRUIDA M. VELDMAN</creator><creator>JOHN GAWAIN ELVIN</creator><creator>THOR LAS HOLTET</creator><creator>STEPHEN SMITH</creator><creator>DANIEL EDWARD TRACEY</creator><creator>MICHAEL WHITE</creator><creator>NICHOLAS W. WARNE</creator><creator>ELAINE J. DERBYSHIRE</creator><creator>ZEHRA KAYMAKCALAN</creator><creator>ALEXANDER ROBERT DUNCAN</creator><creator>STUART FRIEDRICH</creator><creator>MICHAEL ROGUSKA</creator><creator>PAUL SAKORAFAS</creator><creator>ANGELA MYLES</creator><scope>EVB</scope></search><sort><creationdate>20140311</creationdate><title>ANTICORPOS HUMANOS QUE SE LIGAM A IL-12 HUMANA E MÉTODOS PARA PRODUÇÃO</title><author>MICHAEL PASKIND ; AMY VENTURINI ; SARAH LEILA DU FOU ; ANGELA WIDOM ; JOCHEN G. SALFELD ; BORIS LABKOVSKY ; SARA CARMEN ; SUBHASHIS BANERJEE ; GEERTRUIDA M. VELDMAN ; JOHN GAWAIN ELVIN ; THOR LAS HOLTET ; STEPHEN SMITH ; DANIEL EDWARD TRACEY ; MICHAEL WHITE ; NICHOLAS W. WARNE ; ELAINE J. DERBYSHIRE ; ZEHRA KAYMAKCALAN ; ALEXANDER ROBERT DUNCAN ; STUART FRIEDRICH ; MICHAEL ROGUSKA ; PAUL SAKORAFAS ; ANGELA MYLES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0721125A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2014</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MICHAEL PASKIND</creatorcontrib><creatorcontrib>AMY VENTURINI</creatorcontrib><creatorcontrib>SARAH LEILA DU FOU</creatorcontrib><creatorcontrib>ANGELA WIDOM</creatorcontrib><creatorcontrib>JOCHEN G. SALFELD</creatorcontrib><creatorcontrib>BORIS LABKOVSKY</creatorcontrib><creatorcontrib>SARA CARMEN</creatorcontrib><creatorcontrib>SUBHASHIS BANERJEE</creatorcontrib><creatorcontrib>GEERTRUIDA M. VELDMAN</creatorcontrib><creatorcontrib>JOHN GAWAIN ELVIN</creatorcontrib><creatorcontrib>THOR LAS HOLTET</creatorcontrib><creatorcontrib>STEPHEN SMITH</creatorcontrib><creatorcontrib>DANIEL EDWARD TRACEY</creatorcontrib><creatorcontrib>MICHAEL WHITE</creatorcontrib><creatorcontrib>NICHOLAS W. WARNE</creatorcontrib><creatorcontrib>ELAINE J. DERBYSHIRE</creatorcontrib><creatorcontrib>ZEHRA KAYMAKCALAN</creatorcontrib><creatorcontrib>ALEXANDER ROBERT DUNCAN</creatorcontrib><creatorcontrib>STUART FRIEDRICH</creatorcontrib><creatorcontrib>MICHAEL ROGUSKA</creatorcontrib><creatorcontrib>PAUL SAKORAFAS</creatorcontrib><creatorcontrib>ANGELA MYLES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MICHAEL PASKIND</au><au>AMY VENTURINI</au><au>SARAH LEILA DU FOU</au><au>ANGELA WIDOM</au><au>JOCHEN G. SALFELD</au><au>BORIS LABKOVSKY</au><au>SARA CARMEN</au><au>SUBHASHIS BANERJEE</au><au>GEERTRUIDA M. VELDMAN</au><au>JOHN GAWAIN ELVIN</au><au>THOR LAS HOLTET</au><au>STEPHEN SMITH</au><au>DANIEL EDWARD TRACEY</au><au>MICHAEL WHITE</au><au>NICHOLAS W. WARNE</au><au>ELAINE J. DERBYSHIRE</au><au>ZEHRA KAYMAKCALAN</au><au>ALEXANDER ROBERT DUNCAN</au><au>STUART FRIEDRICH</au><au>MICHAEL ROGUSKA</au><au>PAUL SAKORAFAS</au><au>ANGELA MYLES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICORPOS HUMANOS QUE SE LIGAM A IL-12 HUMANA E MÉTODOS PARA PRODUÇÃO</title><date>2014-03-11</date><risdate>2014</risdate><abstract>Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12 ) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BRPI0721125A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS SPIRITS VINEGAR WINE |
| title | ANTICORPOS HUMANOS QUE SE LIGAM A IL-12 HUMANA E MÉTODOS PARA PRODUÇÃO |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A37%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MICHAEL%20PASKIND&rft.date=2014-03-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0721125A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |